Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism

Neuropsychopharmacology

Volumn 38, Issue 12, 2013, Pages 2484-2497

  Al Hasani, Ream ^a   McCall, Jordan G ^a   Foshage, Audra M ^a   Bruchas, Michael R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

b adrenergic receptors; cocaine; kappa opioid receptor; locus coeruleus; norepinephrine; reinstatement

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; AUTORECEPTOR; BETAXOLOL; CLONIDINE; COCAINE; KAPPA OPIATE RECEPTOR; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG SEEKING BEHAVIOR; LOCOMOTION; LOCUS CERULEUS; MALE; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BETAXOLOL; CLONIDINE; COCAINE; CONDITIONING (PSYCHOLOGY); DRUG-SEEKING BEHAVIOR; LOCUS COERULEUS; MALE; MICE; MICE, INBRED C57BL; NALTREXONE; PROPANOLAMINES; PROPRANOLOL; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, OPIOID, KAPPA;

EID: 84888352926     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.151     Document Type: Article

References (76)

1. Aghajanian GK, VanDErMaelen CP (1982). Alpha 2-adrenoceptormediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science 215: 1394-1396. (Pubitemid 12129720)
2. Arnsten AF, Goldman-Rakic PS (1984). Selective prefrontal cortical projections to the region of the locus coeruleus and raphe nuclei in the rhesus monkey. Brain Res 306: 9-18. (Pubitemid 14090440)
3. Aston-Jones G, Rajkowski J, Cohen J (1999). Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 46: 1309-1320. (Pubitemid 30114448)
4. Bale TL, Vale WW (2004). CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44: 525-557. (Pubitemid 38263852)
5. Beardsley PM, Howard JL, Shelton KL, Carroll FI (2005). Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antiDEpressant-like effects in rats. Psychopharmacology (Berl) 183: 118-126. (Pubitemid 41484188)
6. Bockstaele EJ, Van, Chan J, Pickel VM (1996a). Input from central nucleus of the amygdala efferents to pericoerulear DEndrites, some of which contain tyrosine hydroxylase immunoreactivity. J Neurosci Res 45: 289-302. (Pubitemid 26322818)
7. Bockstaele EJ, Van, Colago EE, Valentino RJ (1996b). Corticotropin- releasing factor-containing axon terminals synapse onto catecholamine DEndrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol 364: 523-534.
8. Bockstaele EJ, Van, Colago EE, Valentino RJ (1998). Amygdaloid corticotropin-releasing factor targets locus coeruleus DEndrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response. J Neuroendocrinol 10: 743-757. (Pubitemid 28446145)
9. Bockstaele EJ, Van, Peoples J, Valentino RJ (1999). A.E. Bennett Research Award. Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents. Biol Psychiatry 46: 1352-1363.
10. Bockstaele EJ, Van, Reyes BAS, Valentino RJ (2010). The locus coeruleus: a key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse. Brain Res 1314: 162-174.
11. Bruchas MR, Land BB, Aita M, Xu M, Barot SK, Li S et al (2007a). Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-DEpenDEnt dysphoria. J Neurosci 27: 11614-11623. (Pubitemid 350006906)
12. Bruchas MR, Land BB, Chavkin C (2010). The dynorphin/kappa opioid system as a modulator of stress-induced and proaddictive behaviors. Brain Res 1314: 44-55.
13. Bruchas MR, Macey TA, Lowe JD, Chavkin C (2006). Kappa opioid receptor activation of p38 MAPK is GRK3-and arrestin-DEpenDEnt in neurons and astrocytes. J Biol Chem 281: 18081-18089. (Pubitemid 44035608)
14. Bruchas MR, Schindler AG, Shankar H, Messinger DI, Miyatake M, Land BB et al (2011). Selective p38a MAPK DEletion in serotonergic neurons produces stress resilience in moDEls of DEpression and addiction. Neuron 71: 498-511.
15. Bruchas MR, Yang T, Schreiber S, DEfino M, Kwan SC, Li S et al (2007b). Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase. J Biol Chem 282: 29803-29811. (Pubitemid 350035286)
16. Carey AN, Borozny K, Aldrich JV, McLaughlin JP (2007). Reinstatement of cocaine place-conditioning prevented by the peptiDE kappa-opioid receptor antagonist arodyn. Eur J Pharmacol 569: 84-89. (Pubitemid 47175877)
17. Carlezon WA Jr, Béguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS et al (2006). DEpressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316: 440-447. (Pubitemid 41832624)
18. Chartoff E, Sawyer A, Rachlin A, Potter D, Pliakas A, Carlezon WA (2012). BlockaDE of kappa opioid receptors attenuates the DEvelopment of DEpressive-like behaviors induced by cocaine withdrawal in rats. Neuropharmacology 62: 167-176.
19. Correll CM, Rosenkranz JA, Grace AA (2005). Chronic cold stress alters prefrontal cortical modulation of amygdala neuronal activity in rats. Biol Psychiatry 58: 382-391. (Pubitemid 41219706)
20. Covington HE 3rd, Miczek KA (2001). Repeated social-DEfeat stress, cocaine or morphine. Effects on behavioral sensitization and intravenous cocaine self-administration "binges.". Psychopharmacology (Berl) 158: 388-398. (Pubitemid 33141315)
21. DElfs JM, Zhu Y, Druhan JP, Aston-Jones G (2000). Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403: 430-434. (Pubitemid 30073092)
22. DEvilbiss DM, Waterhouse BD, Berridge CW, Valentino R (2012). Corticotropin-releasing factor acting at the locus coeruleus disrupts thalamic and cortical sensory-evoked responses. Neuropsychopharmacology 37: 2020-2030.
23. Ebner SR, Roitman MF, Potter DN, Rachlin AB, Chartoff EH (2010). DEpressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with DEcreased phasic dopamine release in the nucleus accumbens. Psychopharmacology (Berl) 210: 241-252.
24. Erb S, Stewart J (1999). A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropinreleasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci 19: RC35.
25. Flavin SA, WinDEr DG (2013). Noradrenergic control of the bed nucleus of the stria terminalis in stress and reward. Neuropharmacology 70: 324-330.
26. Gehrke BJ, Chefer VI, Shippenberg TS (2008). Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum. Psychopharmacology (Berl) 197: 509-517.
27. Graziane NM, Polter AM, Briand LA, Pierce RC, Kauer JA (2013). Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity. Neuron 77: 942-954.
28. Al-Hasani R, Bruchas MR (2011). Molecular mechanisms of opioid receptor-DEpenDEnt signaling and behavior. Anesthesiology 115: 1363-1381.
29. Horan P, Taylor J, Yamamura HI, Porreca F (1992). Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther 260: 1237-1243.
30. Hough LB, Nalwalk JW, Chen Y, Schuller A, Zhu Y, Zhang J et al (2000). Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice. Brain Res 880: 102-108.
31. Jackson KJ, McLaughlin JP, Carroll FI, Damaj MI (2012). Effects of the kappa opioid receptor antagonist, norbinaltorphimine, on stress and drug-induced reinstatement of nicotine-conditioned place preference in mice. Psychopharmacology (Berl) 226: 763-768.
32. Jodo E, Aston-Jones G (1997). Activation of locus coeruleus by prefrontal cortex is mediated by excitatory amino acid inputs. Brain Res 768: 327-332. (Pubitemid 27433508)
33. Jodo E, Chiang C, Aston-Jones G (1998). Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons. Neuroscience 83: 63-79. (Pubitemid 28068039)
34. Kim T, McCall JG, Jung YH, Huang X, Siuda ER, Li Y et al (2013). Injectable, cellular-scale optoelectronics with applications for wireless optogenetics. Science 340: 211-216.
35. Knoll AT, Muschamp JW, Sillivan SE, Ferguson D, Dietz DM, Meloni EG et al (2011). Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Biol Psychiatry 70: 425-433.
36. Koob GF, Le Moal M (2008). Addiction and the brain antireward system. Annu Rev Psychol 59: 29-53.
37. Kreibich A, Reyes BAS, Curtis AL, Ecke L, Chavkin C, Van Bockstaele EJ et al (2008). Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system. J Neurosci 28: 6516-6525.
38. Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C (2008). The dysphoric component of stress is encoDEd by activation of the dynorphin kappa-opioid system. J Neurosci 28: 407-414.
39. Land BB, Bruchas MR, Schattauer S, Giardino WJ, Aita M, Messinger D et al (2009). Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci USA 106: 19168-19173.
40. Lemos JC, Roth CA, Chavkin C (2011). Signaling events initiated by kappa opioid receptor activation: quantification and immunocolocalization using phospho-selective KOR, p38 MAPK, and K(IR) 3.1 antibodies. Methods Mol Biol 717: 197-219.
41. Lemos JC, Wanat MJ, Smith JS, Reyes BA, Hollon NG, Van Bockstaele EJ et al (2012). Severe stress switches CRF action in the NAc from appetitive to aversive. Nature 490: 402-406.
42. Li C, Pleil KE, Stamatakis AM, Busan S, Vong L, Lowell BB et al (2012). Presynaptic inhibition of gamma-aminobutyric acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling. Biol Psychiatry 71: 725-732.
43. Limberger N, Späth L, Hölting T, Starke K (1986). Mutual interaction between presynaptic alpha 2-adrenoceptors and opioid kappareceptors at the noradrenergic axons of rabbit brain cortex. Naunyn SchmieDEbergs Arch Pharmacol 334: 166-171. (Pubitemid 16000285)
44. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr et al (2003). AntiDEpressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305: 323-330. (Pubitemid 36373867)
45. Mantsch JR, Weyer A, Vranjkovic O, Beyer CE, Baker DA, Caretta H (2010). Involvement of noradrenergic neurotransmission in the stress-but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for b-2 adrenergic receptors. Neuropsychopharmacology 35: 2165-2178.
46. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux J-P et al (2005). Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436: 103-107. (Pubitemid 40966193)
47. McLaughlin JP, Marton-Popovici M, Chavkin C (2003). Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23: 5674-5683. (Pubitemid 36807845)
48. Moore RY (1978). Catecholamin innervation of the basal forebrain. I. The septal area. J Comp Neurol 177: 665-684.
49. Nobis WP, Kash TL, Silberman Y, WinDEr DG (2011). b-Adrenergic receptors enhance excitatory transmission in the bed nucleus of the stria terminalis through a corticotrophinreleasing factor receptor-DEpenDEnt and cocaine-regulated mechanism. Biol Psychiatry 69: 1083-1090.
50. Phelix CF, Liposits Z, Paull WK (1992). Monoamine innervation of bed nucleus of stria terminalis: an electron microscopic investigation. Brain Res Bull 28: 949-965.
51. Potter DN, Damez-Werno D, Carlezon WA Jr, Cohen BM, Chartoff EH (2011). Repeated exposure to the k-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity. Biol Psychiatry 70: 744-753.
52. Redila VA, Chavkin C (2008). Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system. Psychopharmacology (Berl) 200: 59-70.
53. Reyes BAS, Chavkin C, van Bockstaele EJ (2009). Subcellular targeting of kappa-opioid receptors in the rat nucleus locus coeruleus. J Comp Neurol 512: 419-431.
54. Reyes BAS, Drolet G, Van Bockstaele EJ (2008). Dynorphin and stress-related peptiDEs in rat locus coeruleus: contribution of amygdalar efferents. J Comp Neurol 508: 663-675. (Pubitemid 351656391)
55. Reyes BAS, Glaser JD, Magtoto R, Van Bockstaele EJ (2006). Proopiomelanocortin colocalizes with corticotropin-releasing factor in axon terminals of the noradrenergic nucleus locus coeruleus. Eur J Neurosci 23: 2067-2077.
56. Reyes BAS, Johnson AD, Glaser JD, Commons KG, Van Bockstaele EJ (2007). Dynorphin-containing axons directly innervate noradrenergic neurons in the rat nucleus locus coeruleus. Neuroscience 145: 1077-1086. (Pubitemid 46454355)
57. Rosenkranz JA, Grace AA (2002). Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. J Neurosci 22: 324-337. (Pubitemid 34033510)
58. Samaha A-N, Mallet N, Ferguson SM, Gonon F, Robinson TE (2004). The rate of cocaine administration alters gene regulation and behavioral plasticity: implications for addiction. J Neurosci 24: 6362-6370. (Pubitemid 38944227)
59. Schindler AG, Messinger DI, Smith JS, Shankar H, Gustin RM, Schattauer SS et al (2012). Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake. J Neurosci 32: 17582-17596.
60. Shaham Y, Erb S, Stewart J (2000a). Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Brain Res Rev 33: 13-33.
61. Shaham Y, Highfield D, DElfs J, Leung S, Stewart J (2000b). Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect inDEpenDEnt of locus coeruleus noradrenergic neurons. Eur J Neurosci 12: 292-302. (Pubitemid 30068434)
62. Shippenberg TS, Zapata A, Chefer VI (2007). Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther 116: 306-321. (Pubitemid 47454747)
63. Shirayama Y, Ishida H, Iwata M, Hazama G-I, Kawahara R, Duman RS (2004). Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antiDEpressant-like effects. J Neurochem 90: 1258-1268. (Pubitemid 39167359)
64. Smith JS, Schindler AG, Martinelli E, Gustin RM, Bruchas MR, Chavkin C (2012). Stress-induced activation of the dynorphin/kopioid receptor system in the amygdala potentiates nicotine conditioned place preference. J Neurosci 32: 1488-1495.
65. Swanson LW (1976). The locus coeruleus: a cytoarchitectonic, Golgi and immunohistochemical study in the albino rat. Brain Res 110: 39-56.
66. Swanson LW, Hartman BK (1975). The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-betahydroxylase as a marker. J Comp Neurol 163: 467-505.
67. Tejeda HA, Counotte DS, Oh E, Rammamoorthy S, Schultz-Kuszak KN, Bäckman CM et al (2013). Prefrontal cortical kappaopioid receptor modulation of local neurotransmission and conditioned place aversion. Neuropsychopharmacology. doi: 10.1038/npp.2013.76.
68. Tzschentke TM (2007). Measuring reward with the conditioned place preference (CPP) paradigm: update of the last DEcaDE. Addict Biol 12: 227-462. (Pubitemid 47196347)
69. Valentino RJ, Foote SL, Page ME (1993). The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann N Y Acad Sci 697: 173-188. (Pubitemid 24028963)
70. Valentino RJ, Page M, Bockstaele E, Van, Aston-Jones G (1992). Corticotropin-releasing factor innervation of the locus coeruleus region: distribution of fibers and sources of input. Neuroscience 48: 689-705.
71. Valentino RJ, Rudoy C, SaunDErs A, Liu XB, Van Bockstaele EJ (2001). Corticotropin-releasing factor is preferentially colocalized with excitatory rather than inhibitory amino acids in axon terminals in the peri-locus coeruleus region. Neuroscience 106: 375-384. (Pubitemid 32889635)
72. Van't Veer A Bechtholt AJ Onvani S Potter D Wang Y Liu-Chen L-Y et al. 2013 Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticit Neuropsychopharmacology 38 1585-1597.
73. Vranjkovic O, Hang S, Baker DA, Mantsch JR (2012). b-adrenergic receptor mediation of stress-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: roles for b1 and b2 adrenergic receptors. J Pharmacol Exp Ther 342: 541-551.
74. Walker BM, Koob GF (2008). Pharmacological eviDEnce for a motivational role of kappa-opioid systems in ethanol DEpenDEnce. Neuropsychopharmacology 33: 643-652.
75. Walker BM, Zorrilla EP, Koob GF (2011). Systemic k-opioid receptor antagonism by nor-binaltorphimine reduces DEpenDEnce-induced excessive alcohol self-administration in rats. Addict Biol 16: 116-119.
76. Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ (2005). Effects of the plant-DErived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors. Psychopharmacology (Berl) 179: 551-558. (Pubitemid 40674756)